PROGENSA PCA3 scanning and diagnosis for Prostrate cancer is finally approved by the FDA. AND it is available now in Malaysia. It is non invasive and uses urine to test. PCA3 is a highly specific to Prostrate cancer. It has marked advantages over the standard PSA test. The PCA3 assay results will be more conclusive to the PSA test.
Browse the internet forPROGENSA PCA3 or call me for further discussion
No comments:
Post a Comment